Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: A phase II Southwest Oncology Group study (S0339)

Por Davies, Angela M., Chansky, Kari, Lara, Primo N., Gumerlock, Paul H., Crowley, John, Albain, Kathy S., Vogel, Stanley J., Gandara, David R.
Publicado em 2009

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102

Por Gralow, Julie R., Barlow, William E., Lew, Danika, Dammann, Kim, Somlo, George, Rinn, Kristine J., Vogel, Stanley J., Wong, Lucas, Livingston, Robert B., Hortobagyi, Gabriel N.
Publicado em 2013